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Abstract
Vascular early response gene (Verge) is a novel immediate early gene that is highly expressed 
during developmental angiogenesis and after ischemic insults in adult brain. However, the role of 
Verge after neonatal injury is not known. In the present study, we investigated the hypothesis that 
Verge contributes to vascular remodeling and tissue repair after neonatal ischemic injury. The 
Rice–Vanucci model (RVM) was employed to induce neonatal stroke in both Verge knockout 
(KO) and wild-type (WT) postnatal day 10 (P10) mice. Histological and behavioral outcomes at 
acute (24 h), subacute (7 days) and chronic (30 days) phases were evaluated. Angiogenesis, 
neurogenesis, and glial scar formation were also examined in the ischemic brain. No significant 
differences in outcomes were found between WT and Verge mice at 24 h or 7 days after stroke. 
However genetic deletion of Verge led to pronounced cystic cavitation, decreased angiogenensis 
and glial scar formation in the ischemic hemisphere compared to WT mice at 30 days. Verge KO 
mice also had significantly worse functional outcomes at 30 days which was accompanied by 
decreased neurogenesis and angiogenesis in the ischemic hemisphere. Our study suggests that 
Verge plays an important role in the induction of neurogenesis and angiogenesis after ischemia, 
contributes to improved tissue repair, and enhances chronic functional recovery.
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1. Introduction
Perinatal arterial ischemic stroke (PAIS), with an incidence of 1/2500 to 1/5000 term 
neonates, is an important cause of hemiplegic cerebral palsy and cognitive impairment in 
children (Cheong and Cowan, 2009). The underlying pathophysiology of PAIS is difficult to 
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study in the human. It is critical to model neonatal stroke in animals to identify and develop 
therapeutic strategies to reduce brain injury in newborns with PAIS. Numerous experimental 
studies have examined potential therapies for neonatal stroke ranging from anti-excitotoxic, 
anti-oxidative, and anti-apoptotic therapies to stem cell replacement and hypothermia 
therapy (Kleman et al., 2010). However, due to the complexity of the response to ischemic 
injury in the brain at present no individual pharmacological agents have been proven 
effective (Lai and Yang, 2011). Novel therapeutic strategies are urgently needed for this 
devastating disease. The active developmental state of the early postnatal brain provides an 
exciting potential therapeutic opportunity, i.e. enhancement of angiogenesis. Angiogenesis, 
especially in a relatively young brain, could represent an effective way to repair the injured 
brain tissue and potentially lead to improved function and recovery. Importantly, 
discovering mechanisms by which repair can recapitulate normal development may have 
implications for adult brain injury as well.
Vascular early response gene (Verge), a novel immediate early gene (IEG), is expressed 
selectively in vascular endothelial cells and platelets (Regard et al., 2004). Verge mRNA 
and protein are rapidly and transiently induced in mature, quiescent vasculature in adult; 
however, they are constitutively expressed at high levels in the endothelium of developing 
tissues in association with angiogenesis in neonatal animals (Regard et al., 2004). Verge 
expression is responsive to local tissue conditions, as transient focal ischemia induced a 
threefold increase in Verge mRNA expression in the ischemic hemisphere. Previous work 
has shown that mice with Verge deletion develop normally, but exhibit reduced edema 
formation after experimental stroke in adulthood, an effect that was independent of infarct 
volumes (Liu et al., 2012c) which were equivalent in Verge KO and WT adult mice. In this 
study, we utilized the RVM (Vannucci and Perlman, 1997) in Verge KO and WT littermate 
mice to induce ischemia at post-natal day 10 (P10) to test the hypothesis that Verge 
activation increases angiogenesis and improves chronic recovery after neonatal stroke.
2. Materials and methods
2.1. Experimental animals
Verge KO (original breeding pairs from Johns Hopkins University as a gift from Dr. Paul 
Worley) and WT C57BL/6 littermates P10 mice were used. The sex ratio of mice was 
balanced by randomly putting equal numbers of male and female pups in each cohort. This 
study was conducted in accordance with NIH guidelines for the care and use of animals in 
research and under protocols approved by the Animal Care and Use Committee of the 
University of Connecticut Health Center.
2.2. RVM model
The RVM was modified for use in mice (Knox et al., 2013). Briefly, P10 mice were 
anaesthetized with 1.5% Isoflurane and placed in the supine position. Body temperature was 
maintained at 36.5 °C with an automated temperature control feedback system. The fur and 
skin of the frontal neck region were disinfected with 70% ethanol, and then a less than 0.5 
cm long midline incision was made to expose the right common carotid artery (CCA). 
Double permanent ligation of CCA was made with 6–0 silk suture, and then the incision was 
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closed and the pups were returned to their dams. Sham mice underwent the same procedure 
except ligation of the right CCA. 1 h after surgery, pups were placed in a 36 °C chamber 
containing 10% oxygen and 90% nitrogen for 45 min, 60 min or 90 min to induce ischemic 
injury. Mice were sacrificed 24 h (acute), 7 days (subacute), or 30 days (chronic) after 
stroke. Pups in the 30-day survival cohort were injected with 5-Bromo-2′-deoxyuridine 
(BrdU, Millipore) (100 mg/kg) i.p. twice a week after VRM modeling (Bartley et al., 2005). 
The corner test was performed by an investigator blinded to stroke/sham and genotype at 7 
days and 30 days after stroke; the score of corner test was determined by the number of right 
turn/right plus left turns as previously described (Li et al., 2004).
2.3. Histological assessment
The infarct was quantified at both the acute and subacute endpoints by triphenyltetrazolium 
chloride (TTC) staining (Liu et al., 2009); brain atrophy was quantified at chronic endpoints 
stroke with cresyl violet (CV) staining as in (Liu et al., 2012a). Brain infarct volume (acute) 
or tissue loss (subacute and chronic endpoints) was calculated as previously described (Liu 
et al., 2009, 2012a). Hemispheric cyst formation was examined when brains were taken out 
of the skulls and confirmed by TTC or CV staining.
2.4. Immunohistochemistry
Pups were sacrificed at 7 days or 30 days after stroke; brains were perfused (Liu et al., 
2012a) and stained with 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI, 1:1000, 
Invitrogen) for nuclei, Verge antibody (obtained as a gift from Dr. Paul Worley in John 
Hopkins University, 1:100) for Verge expression in the vessel, Endoglin (CD105, 1:20, 
Dako) and Von Willebrand factor (VWF, 1:100, Santa-Cruz) for angiogenesis (Starke et al., 
2011; Tan et al., 2013), anti-BrdU (1:20, Sigma–Aldrich) was used to identify new-born 
cells (Biron et al., 2011), anti-NeuN for neurons (Liu et al., 2009), and glial fibrillary acidic 
protein (GFAP, 1:200, Dako) for glial scar formation (Bao et al., 2012). Secondary 
antibodies used were Alexa Fluor dyes 488 and 594 (1:1000, Invotrogen), complementary to 
the species of primary antibodies. The signal was visualized with a Zeiss Axiovert 200M 
microscope (Carl Zeiss) and captured with Zeiss LSM510 Meta software (Liu et al., 2012b). 
The fluorescent intensity of the signal was analyzed by ImageJ software (NIH).
2.5. Statistical analysis
Investigators were blinded to mouse genotype and treatment (sham vs. stroke) for all 
experiments. Mice with abnormal body weights and behavior (e.g. body shaking, limp, etc.) 
before VRM were excluded. Data from individual experiments were presented as Mean ± 
SEM and analyzed with t-test for two groups, and two-way ANOVA for multiple group 
comparison. The hemispheric cyst formation data was presented as the count of cysts/total 
count of samples in the group and analyzed with Fisher’s Exact Test. P < 0.05 was 
considered statistically significant for all data.
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3.1. Acute and subacute outcomes of 90-min neonatal stroke
Brain injury varies in the mouse RVM depending on the time exposed to 10% oxygen with a 
range from 15 min (Jiang et al., 2008) to 2.5 h (Nakanishi et al., 2009) reported in the 
literature. We chose the median time (90 min) at the beginning of this study. 24 h after a 90 
min 10% oxygen exposure, visible infarct was seen in the right (ipsilateral) hemisphere in 
both WT and KO pups (Fig. 1A-i); however, quantitative analysis revealed no difference in 
infarct volumes between the two strains (Fig. 1A-ii). Next we extended the survival time to 
7 days to examine subacute stroke outcomes. Stroke mice of both strains had a significant 
preference in the corner test compared to sham mice. Surprisingly, we found significantly 
more gross hemispheric cyst formation in KO brains compared to WT mice (KO vs. WT: 
6/6 vs. 2/7; P = 0.02) (Fig. 1B-i and ii); however quantification of either tissue loss (Fig. 1B-
iii) or behavioral deficits in the corner test (Fig. 1B-iv) revealed no differences between 
genotypes.
3.2. Angiogenesis and glial scar formation after 7 days of 90 min neonatal stroke
Surprised by the distinct phenotype of hemispheric cyst formation seen in Verge KO mice 
after 7 days of 90 min stroke, we hypothesized Verge may have a role in promoting post-
stroke angiogenesis which can prevent cavitation in the ischemic injury (Leker et al., 2009). 
CD105 is an important marker for angiogenesis (Duff et al., 2003). We performed triple 
labeling of brain slices with CD105, Verge, and DAPI. Consistent with our previous 
findings in adult mice, Verge expression was increased after stroke in WT pups (Fig. 2B and 
D). Verge also co-localized with CD105 (Fig. 2B). Stroke induced a significant increase in 
CD105 expression only in WT mice, and KO pups expressed significantly less CD105 
compared with their WT counterparts (Fig. 2B and C). The decreased angiogenesis in KO 
vs. WT brains after ischemia was further confirmed by VWF staining (Fig. 2E).
Glial scars formed early in the ischemic brain have a beneficial role in curbing ischemic 
lesion (Beck et al., 2008). We used GFAP staining to identify glial scars and found 
dispersed, tangled GFAP positive signals in both WT and KO ipsilateral hemispheres (Fig. 
2F). WT pups had significantly denser glial scars than KO pups (Fig. 2F and G). The 
astrocytes comprising the scar exhibited activated morphology of plump cell bodies and 
short processes (Fig. 2F: the insert). In sham mice, only a few GFAP positive astrocytes 
were seen near the edge of the cortex.
3.3. Acute and subacute outcomes after 60-min neonatal ischemia
To exclude the possibility that the 90 min ischemic insult was too severe to reveal any 
difference in stroke outcomes between KO and WT pups due to the “ceiling effect”, we 
shortened the ischemic time to 60 min. Again, 24 h after stroke, no difference in infarct 
volumes was seen between the two cohorts (Fig. 3A); significantly more hemispheric cyst 
formation was seen in KO vs. WT brains after 7 days of stroke (KO vs. WT: 5/6 vs. 0/7; P = 
0.004) (Fig. 3B-i), but similar to what was seen with a 90 min insult, there was no 
significant difference in tissue loss (Fig. 3B-ii) or in the results of corner testing (Fig. 3B-iii) 
between KO and WT pups. We further reduced the stroke time to 45 min in our model, but 
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the infarct at day 7 was almost undetectable and non-measurable in most of the brains, and 
no difference in corner test scores was seen between sham and stroke mice (data not shown).
3.4. Chronic outcomes of 60-min neonatal stroke
The phenotype of hemispheric cyst development in KO pups was striking. We hypothesized 
that these early cysts may be important to more chronic functional and histological 
outcomes. Therefore another cohort of pups was examined that were subjected to a 60 min 
ischemic challenge and allowed to survive for 30 days. Histological assessment showed that 
the majority of KO brains (5/7) had visible cyst formation; however, the cavity was only 
seen in one WT brain (1/8). Evident atrophy was seen in the ipsilateral hemisphere of both 
KO and WT mice as indicated by an enlarged ipsilateral ventricle due to volume loss (Fig. 
4A). Since atrophy could conceal the presence of a previously formed cavity, statistical 
analysis of cavity formation is not applicable for this chronic cohort. The quantitative 
analysis of remaining tissue in the ischemic brain showed that KO pups had significantly 
more ipsilateral tissue loss than WT mice (Fig. 4B). Correspondingly, KO mice had 
significantly higher corner test scores than their WT counterparts (Fig. 4C).
3.5. Angiogenesis, neurogenesis, and glial scar formation assessed at a chronic endpoint 
after neonatal stroke
Next we examined CD105 and Verge expression at 30 days after a 60 min stroke. 
Surprisingly increased expression of Verge after stroke persisted at 30 days (Fig. 5A and C), 
accompanied by the same pattern of CD105 expression (Fig. 5A and B). Similar to the early 
time points (Fig. 2B), CD105 positive vessels also expressed Verge, suggesting a supportive 
role for Verge in angiogenesis. The decreased angiogenesis in KO vs. WT brains after 
ischemia was further confirmed by VWF staining (Fig. 2D). It has been demonstrated that 
increased angiogenesis leads to enhancement of neurogenesis (Jin et al., 2002; Taguchi et 
al., 2004; Wang et al., 2004; Zhang et al., 2003). In order to determine whether Verge also 
has an impact on neurogenesis post-ischemia, we injected both WT and KO mice in the 
chronic endpoint cohort with BrdU to examine the new-born cells. WT pups had 
significantly more BrdU positive cells in the ipsilateral hemisphere than KO mice (Fig. 5E 
and F). Almost all CD105 positive vessels were co-labeled with BrdU, indicating the 
presence of post-stroke angiogenesis. We also performed double staining with BrdU and 
NeuN, and found WT brains had more co-localized signals than KO brains 30 days after 
ischemia (Fig. 5G). Finally we examined chronic glial scar formation in the ipsilateral 
hemisphere of both WT and KO pups. Surprisingly a very distinct phenotype of chronic glial 
scar formation was observed between the two strains (Fig. 5H). In WT brains, dispersed 
GFAP signals were still seen in the ipsilataral hemisphere, although the astrocytes exhibited 
smaller bodies and finer processes (Fig. 5H: the insert) compared to those in early phase of 
stroke (Fig. 2F: the insert). However, very dense and thick GFAP signals were seen along 
the cavity wall in which DAPI staining was absent or attenuated, suggesting most of these 
GFAP signals are protein deposition (“aged” scars) rather than astrocytes.
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Verge is an important IEG whose function remains unclear. Verge is very highly expressed 
in the vasculature and in platelets during development and is important in angiogenesis 
(Regard et al., 2004). We have previously shown that Verge is induced by stroke in the adult 
brain. However, as this is a developmentally regulated gene, and is only highly-expressed in 
select vessels after an ischemic injury in adulthood (Regard et al., 2004), we hypothesized 
that Verge may have a greater impact after a developmentally induced injury such as 
perinatal stroke. The present study is the first report of the effects of loss of Verge, after 
ischemic injury in the neonatal brain. Several important results were found. Firstly, acute 
and subacute stroke outcomes, both histological (infarct) and behavioral (corner turning 
preference) were not affected by Verge deletion. This is consistent with our previous study 
in adult animals (Liu et al., 2012c). However, loss of Verge led to significant differences in 
chronic outcome after an ischemic injury, suggesting that Verge signaling is important in 
stroke recovery. Secondly, loss of Verge led to a dramatic increase in ipsilateral cyst 
formation in the neonatal brain. Stroke-induced cyst formation was seen at subacute stage of 
ischemia (7 days), and was still evident 30 days after stroke in Verge KO mice. This was 
related to a reduction in both tissue repair and functional recovery. Thirdly, a significant 
difference in glial scar formation was found in WT versus KO pups. At an early stage post-
ischemia, enhanced glial scar formation was seen in WT compared to KO brains; however, 
KO but not WT brains exhibited GFAP deposition along the cyst wall at chronic endpoints. 
Finally, neurogenesis and angiogenesis were compromised in the ischemic brain of Verge 
KO mice, which was closely related to the glial scar formation and stroke outcomes.
A previous study examined the role of Verge in experimental stroke induced by 90 min 
middle cerebral artery occlusion (MCAO) in adult mice and found loss of Verge did not 
affect acute stroke outcomes (i.e., infarct size) (Liu et al., 2012c). The lack of acute effects 
of Verge deletion extends to neonates as shown in this study. Infarct volumes early after 
stroke were measured by TTC staining, a marker of tissue dehydrogenase and mitochondrial 
dysfunction that occurs in both the core and penumbra (Benedek et al., 2006; Tureyen et al., 
2004). The pathology of the penumbra is traditionally considered as a one-dimensional, 
linear progression from initial injury to final infarct; however it is now apparent that the 
penumbra may not passively die over time, but can also actively recover (Lo, 2008a, b). 
Therefore, outcomes at the early stage of stroke tend to be severer than that of the recovery 
stage, a time when neurological deficits reflect more closely the size and location of the 
structural lesion that is much smaller than the previous combination of core and penumbra 
(Liu et al., 2009). The dynamic progress of infarct typically occurs over a few days in 
ischemic brains of WT mice; however, in brains of Verge KO mice, the ischemic tissue 
developed much quicker and more completely into the core, and was more likely to form 
necrotic cyst. Interestingly these early differences were not reflected in either behavioral or 
histological assessments of tissue injury, however the lack of post-stroke angiogenesis at 
even 7 days of injury set the stage for cyst formation, later enhanced tissue loss, and poorer 
functional outcomes.
Our data provide mechanistic clues as to why KO pups develop more cystic cavitation after 
injury and resultantly lose more tissue in the ischemic hemisphere than WT mice at 30 days. 
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Verge expression was significantly increased in the ipsilateral hemisphere at both early and 
chronic stages of ischemia, and this was associated with up-regulated expression of CD105 
and VWF, increased glial scar formation (GFAP), and an enhancement in the number of 
BrdU and NeuN positive cells. These data suggest that active angiogenesis and neurogenesis 
occurs in WT ischemic brains after neonatal injury that is impaired in Verge KO mice. 
Verge has the potential to induce angiogenesis and thus improved formation of the 
neurogenic niche (Young et al., 2011). This may keep the penumbral area active in cell 
proliferation and tissue repair. In cell culture models using rat brain endothelial cells that 
express Verge, treatment with phorbol 12-myristate 13-acetate, a potent inducer of Verge 
expression, led to a reorganization of the actin cytoskeleton and the formation of 
paracellular gaps (Regard et al., 2004), suggesting a positive role for Verge in tissue repair. 
Neurogenesis and angiogenesis start to occur days after stroke (Lanfranconi et al., 2011) and 
have an effect in reducing necrotic cavity formation (Leker et al., 2009; Ohta et al., 2004; 
Osaka et al., 2010). Knockout of Verge suppresses angiogenesis so much so that ischemia 
could not even induce a significant increase in CD105 expression compared to Verge KO 
sham mice (Fig. 2B and C), probably due to the “floor effect”.
Glial scar formation may also have a protective effect early after ischemic injury in the 
brain. The glial scar protects healthy brain areas from exposure to toxic substances and 
cellular debris in the injured tissue, repairs the BBB, and prevents an excessive hyper-
inflammatory response to the infarct (Beck et al., 2008; Kahle and Bix, 2013; Li et al., 
2005). Therefore, glial scar formation early after stroke can help isolate injured tissue and 
limit necrotic cyst formation. The beneficial effects of glial scar formation correlated with 
the occurrence of necrotic cysts 7 days after neonatal injury. However, in the chronic phase 
of ischemic injury, the glial scar becomes a physical and chemical detriment to repair (Silver 
and Miller, 2004; Yiu and He, 2006). This was also reflected in the appearance of the glial 
scars 30 days after stroke, which were thicker, more disorganized and fibrillary along the 
cyst wall. This appears to form a mechanical obstacle to angiogenesis and neurogensis. Glial 
scar was also apparent in WT ischemic brains at chronic endpoints, but the morphology was 
very distinct from that of KO mice. The scar consists of quiescent astrocytes with smaller 
bodies and finer processes compared to those seen at early stage of ischemia. It is possible 
that this early scar in WT brains provides a tissue “scaffold” for angiogenesis and 
neurogenesis. When Verge is absent, less glial scar was formed in the early phase of 
ischemia and the scar that appears later after injury is likely detrimental in the chronic phase.
There are several caveats that need to be recognized when interpreting this data. We only 
compared the ischemic responses of Verge KO to WT by examining the effects of loss of 
Verge. Whether enhancement of Verge signaling has any effect on either ischemic damage 
or recovery is unknown and awaits future studies. We only examined angiogenesis and glial 
scar formation at 7 days and 30 days after ischemia; therefore how the tissue in the ischemic 
brain evolved between these two time points is unknown. The third caveat is that although 
we examined chronic recovery at 30 days, this is still not long enough to examine the effect 
of neonatal stroke and Verge manipulation on adult behavioral recovery, as these 40 day 
animals are considered “adolescent” (Harrison, 2011). However, it is most likely that the 
changes that were seen at 30 days would persist into adulthood with WT mice continuing to 
improve, and continued deficits in the KO mice. The cavitation seen in the KO brains 30 
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days after stroke is likely permanent and not amenable to repair. Finally, since the sex of 
animals was equally balanced in the present study, we cannot conclude if there was an effect 
of sex on either stroke outcomes or on angiogenesis or neurogenesis. The effect of Verge on 
neonatal stroke merits further investigation.
In summary, Verge KO mice develop more hemispheric cyst formation compared to their 
WT counterparts when subjected to ischemia. This was related to a significantly diminished 
level of angiogenesis/neurogenesis in the KO mice. Loss of Verge led to a decrease in early 
(7 day) glial scar formation, which was more robust in WT mice. However at 30 days, the 
scar was more dysmorphic, thicker and disorganized in the KO mice, which was correlated 
with cyst formation, tissue loss, and poorer behavioral outcomes. Knockout of Verge had no 
effect on acute and subacute stroke outcomes (as measured by infarct volumes); however, 
stroke recovery at more chronic stages is strikingly compromised in KO mice. Verge 
activation promotes neurogenesis and angiogenesis after ischemia, and enhances chronic 
stroke recovery, suggesting that investigating Verge signaling may have translational 
potential.
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MCAO middle cerebral artery occlusion
NeuN neuronal nuclear antigen
PAIS perinatal arterial ischemic stroke
P10 post-natal day 10
RVM Rice–Vanucci model
TTC triphenyltetrazolium chloride
Verge vascular early response gene
VWF Von Willebrand factor
WT wild-type
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Stroke outcomes in Verge KO and WT P10 mice subjected to 90-min stroke (RVM) 
followed by 24-h and 7-day survival. (A) Stroke outcomes in the 90 min stroke plus 24 h 
survival cohort. (A-i) Representative coronal brain sections of TTC staining: white dotted 
line shows the midline of the brain; black dotted line illustrates the borderline of the infarct; 
red color area: unaffected tissue; white color area: infarct tissue. (A-ii) quantification of 
infarct volumes; n = 6/group. (B) Stroke outcomes in the 90 min stroke plus 7 days survival 
cohort. (B-i) Gross examination of the cyst in the ischemic hemisphere: the white arrow 
indicates the cyst in the KO ipsilateral hemisphere. (B-ii) Representative coronal brain 
sections of TTC staining. (B-iii) Quantification of infarct volumes; n = 7 in WT group; n = 
6, KO. (B-iv) Scores of Corner test; *P < 0.05 and **P > 0.05. (For interpretation of the 
references to color in this figure legend, the reader is referred to the web version of the 
article.)
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Angiogenesis and glial scar formation in the cohort of 90 min stroke plus 7 days survival. 
(A) The black box in a TTC-stained coronal brain section indicates the area of interest to do 
the immunofluorescent staining. (B) Representative pictures (20×) of CD105, Verge 
antibody and DAPI staining in KO and WT ipsilateral hemispheres; scale bar = 50 μm. (C) 
Quantification of CD105 fluorescent intensity. *P < 0.05, **P < 0.01; n = 6/group. (D) 
Quantification of Verge fluorescent intensity. *P < 0.05 vs. sham; n = 6/group. (E) 
Representative pictures (20×) of VWF antibody staining in KO and WT ipsilateral 
hemispheres; scale bar = 50 μm. (F) Representative pictures (10×) of GFAP, DAPI staining 
in KO and WT ipsilateral hemispheres; scale bar = 50 μm. In the GFAP/WT picture, the 
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insert box (100×) indicates the same astrocyte as the one pointed by the arrow. (G) 
Quantification of GFAP fluorescent intensity. *P < 0.05 vs. WT group; n = 6/group.
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Stroke outcomes from the cohort of 60 min stroke + 24 h/7 days survival. (A) Total infarct 
volumes show no significant difference between KO and WT mice of 60 min stroke + 24 h 
survival cohort; n = 7/group. (B) Outcomes from the cohort of 60 min stroke + 7 days 
survival. (B-i) Representative coronal brain sections of TTC staining; (B-ii) quantification of 
infarct volumes showed no difference between KO and WT mice, n = 7 (WT), n = 6 (KO). 
(B-iii) Scores of Corner test; *P < 0.05 and **P > 0.05.
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Chronic stroke outcomes from the cohort of 60 min stroke + 30 days survival. (A) 
Representative coronal brain sections of CV staining. The right ventricles of both WT and 
KO mice are larger compared to the left. In the WT brain, the right striatum and cortex are 
smaller than the ones on the left; there is cavity formation in the ipsilateral hemisphere of 
the KO brain. (B) Tissue loss in ipsilateral hemispheres of WT and KO mice. *P < 0.05 vs. 
KO group; n = 8(WT), n = 7(KO). (C) Scores of Corner test 30 days after 60 min stroke. *P 
< 0.05.
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Angiogenesis, neurogenesis, and glial scar formation in the cohort of 60 min stroke + 30 
days survival. (A) Representative pictures (20×) of CD105, Verge antibody and DAPI 
staining in KO and WT ipsilateral hemispheres; scale bar = 50 μm. (B) Quantification of 
CD105 fluorescent intensity. *P < 0.05; n = 8(WT), n = 7(KO). (C) Quantification of Verge 
fluorescent intensity. *P < 0.05 vs. sham; n = 8/group. (D) Representative pictures (20×) of 
VWF antibody staining in KO and WT ipsilateral hemispheres; scale bar = 50 μm. (E) 
Representative pictures (20×) of CD105 and BrdU staining; scale bar = 50 μm. (F) 
Quantification of BrdU fluorescent intensity; *P < 0.05; n = 8(WT), n = 7(KO). (G) 
Representative pictures (20×) of BrdU and NeuN double staining in KO and WT ipsilateral 
hemispheres; scale bar = 50 μm. (H) Representative pictures (10×) of GFAP, DAPI staining 
in KO and WT ipsilateral hemispheres; scale bar = 50 μm. In GFAP/WT picture, the insert 
box (100×) indicates the same astrocyte as the one pointed by the arrow. In the DAPI/KO 
picture, the arrow indicates the area of no DAPI signals.
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